UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000019472
Receipt No. R000022518
Scientific Title Shotgun Proteomics and Biomaker Discovery in Pulmonary Diseases
Date of disclosure of the study information 2015/10/23
Last modified on 2019/04/26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Shotgun Proteomics and Biomaker Discovery in Pulmonary Diseases
Acronym Proteomics in Pulmonary Diseases
Scientific Title Shotgun Proteomics and Biomaker Discovery in Pulmonary Diseases
Scientific Title:Acronym Proteomics in Pulmonary Diseases
Region
Japan

Condition
Condition pulmonary diseases
Classification by specialty
Pneumology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Shotogun proteomic and biomarker discovery
Basic objectives2 Others
Basic objectives -Others Identification of biomarkers for pulmonary diseases
Trial characteristics_1 Exploratory
Trial characteristics_2 Others
Developmental phase Not applicable

Assessment
Primary outcomes Association with disease severity and prognisis
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients with pulmonary diseases
Key exclusion criteria Not applicapable
Target sample size 160

Research contact person
Name of lead principal investigator
1st name Takafumi
Middle name
Last name Suda
Organization Hamamatsu University School of Medicine
Division name Second Division, Department of Internal Medicine
Zip code 431-3192
Address 1-20-1 Handayama Higashi-ku, Hamamatsu, Shizuoka 431-3129 Japan
TEL +81-53-435-2263
Email yuzosuzu@hama-med.ac.jp

Public contact
Name of contact person
1st name Yuzo
Middle name
Last name Suzuki
Organization Hamamatsu University School of Medicine
Division name Second Division, Department of Internal Medicine
Zip code 431-3192
Address 1-20-1 Handayama Higashi-ku, Hamamatsu, Shizuoka 431-3129 Japan
TEL +81-53-435-2263
Homepage URL
Email yuzosuzu@hama-med.ac.jp

Sponsor
Institute Second Division, Department of Internal Medicine,Hamamatsu University School of Medicine
Institute
Department

Funding Source
Organization Second Division, Department of Internal Medicine,Hamamatsu University School of Medicine
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor National Hospital Organization, Tenryu Hospital
Serrei Mikatahara Hospital
Shizuoka General Hospital
Iwata City Hospital
Name of secondary funder(s)

IRB Contact (For public release)
Organization Hamamatsu University School of Medicine
Address 1-20-1, Handayama, Higashi-ku, Hamamatsu, Japan
Tel 053-435-2263
Email yuzosuzu@hama-med.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 10 Month 23 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2015 Year 10 Month 23 Day
Date of IRB
2015 Year 10 Month 05 Day
Anticipated trial start date
2015 Year 11 Month 01 Day
Last follow-up date
2020 Year 09 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Study design: multicenter case control study
Objective:Patients with pulmonary diseases, admittedd at our institute between Oct 2015 to Sep 2018.
Measurements:Blood, Sputum, clinical data

Management information
Registered date
2015 Year 10 Month 23 Day
Last modified on
2019 Year 04 Month 26 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022518

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.